Session Information
-
WCLC 2021
2021 World Conference on Lung Cancer
Presentation Date(s):- September 8 - 14, 2021
- Total Presentations: 1107
All times listed are in Mountain Time MDT (UTC-6:00)
PL - Plenary
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
FP - Featured Posters
P - Posters
WS - Workshops
IS - Industry Symposium
MTE - Meet the Expert
BEDG - Brain Exchange Discussion Groups
September 8 Wed
Sep 8 Thursday
September 9 Thu
Sep 9 Friday
September 10 Fri
Sep 10 Saturday
September 11 Sat
Sep 11 Sunday
September 12 Sun
Sep 12 Monday
September 13 Mon
Sep 13 Tuesday
September 14 Tue
Sep 14
-
+
FP03 - Immuno-Biology and Novel Immunotherapeutics (Phase I and Translational)
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters (Featured)
- Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
-
+
FP03.03 - ECOG PS of 0-1 and Very High PD-L1 Expression ≥90% Are Associated With Clinical Benefit From First-Line Chemo-Immunotherapy in Advanced NSCLC
00:00 - 00:00 | Presenter: Biagio Ricciuti
- Abstract
Loading...
-
+
P56 - Predictive Tumor Based Assays/ Biomarkers/ Pathology - Histopathology
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Predictive Tumor Based Assays/ Biomarkers/ Pathology
-
+
P56.01 - Semiquantitative Assessment of Tumor Spread Through Air Spaces in a Historic Cohort of Lung Adenocarcinomas Following Open Surgical Resection
00:00 - 00:00 | Presenter: WEIWEI SHI
- Abstract
Loading...
-
+
ES14 - Liquid Biopsy and Other Non-invasive Diagnostic Modalities*
- 18:15 - 18:50
- 9/14/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Education Session
- Track: Liquid Biopsy and Other Non-invasive Diagnostic Modalities
- Moderators:Lynette Sholl
-
+
ES14.01 - Incorporating ctDNA Testing into Management of Advanced NSCLC Patients
18:15 - 18:17 | Presenter: Natasha Leighl
- Abstract
No abstract available for this presentation
-
+
ES14.02 - Technical Considerations/Pitfalls in ctDNA Testing in Advanced NSCLC Patients
18:17 - 18:19 | Presenter: Maria Arcila
- Abstract
No abstract available for this presentation
-
+
ES14.03 - Liquid Biopsy and Early NSCLC Detection
18:19 - 18:21 | Presenter: Christian Rolfo
- Abstract
Loading... -
+
ES14.04 - ctDNA for Minimal Residual Disease Detection
18:21 - 18:23 | Presenter: Max Diehn
- Abstract
No abstract available for this presentation
-
+
ES14.05 - Live Discussion with Speakers
18:23 - 18:50
- Abstract
No abstract available for this presentation
